Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?

Transarterial chemoembolization (TACE) has been considered the standard treatment for intermediate-stage hepatocellular carcinoma (HCC). However, intermediate‐stage HCC is highly heterogeneous with a broad population with varying tumour burdens, liver function. This suggests that TACE monotherapy tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jun, Wen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001928/
https://www.ncbi.nlm.nih.gov/pubmed/35425716
http://dx.doi.org/10.3389/fonc.2022.824799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001928/
https://www.ncbi.nlm.nih.gov/pubmed/35425716
http://dx.doi.org/10.3389/fonc.2022.824799

Ejemplares similares